Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and local tolerability of topically applied heparin cutaneous spray in arteriovenous fistula function
2011-000455-16Phase 2Completed
- Sponsor
- Cyathus Exquirere
- Start
- Mar 2011
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in arteriovenous fistula dysfunction and chronic kidney disease (CKD) comparing Heparin spray with Placebo spray (2 arms). Primary endpoints: Suitability of AVF for dialysis at week 12 and Suitability of AVF for dialysis at week 24. Started Mar 2011; status: completed.
02
Drugs
heparin
03
Conditions
arteriovenous fistula dysfunctionchronic kidney disease (CKD)
Beyond the preview
Go deeper on 2011-000455-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-000455-16.